Use of various antigens including antigens from mycoplasma bovis in multivalent vaccine composition

Details for Australian Patent Application No. 2009309041 (hide)

Owner Boehringer Ingelheim Vetmedica, Inc.

Inventors Knittel, Jeffrey; Beck, Michael; Hayes, Phillip Wayne

Agent Spruson & Ferguson

Pub. Number AU-A-2009309041

PCT Pub. Number WO2010/051210

Priority 61/110,286 31.10.08 US

Filing date 22 October 2009

Wipo publication date 6 May 2010

International Classifications

A61K 39/02 (2006.01) Medicinal preparations containing antigens or antibodies - Bacterial antigens

C12N 1/36 (2006.01) Micro-organisms, e.g. protozoa - Adaptation or attenuation of cells

A61P 31/04 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

17 March 2011 PCT application entered the National Phase

  PCT publication WO2010/051210 Priority application(s): WO2010/051210

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009309044-Differentiation of human embryonic stem cells to the pancreatic endocrine lineage

2009309039-Reduced waste cleaning methods for oil well related systems